InVivo Biosystems

Eugene, United States

InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.

Apr 2025

Grant

Biotechnology Genetics Life Science Neuroscience Therapeutics

Top Investors

Rogue Venture Partners Oregon Venture Fund Portland Seed Fund National Institutes of Health Cascade Seed Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about InVivo Biosystems

Who are InVivo Biosystems's investors?

InVivo Biosystems's investors include Rogue Venture Partners, Oregon Venture Fund, Portland Seed Fund, National Institutes of Health, Cascade Seed Fund.

Where is InVivo Biosystems headquartered?

InVivo Biosystems is headquartered in Eugene, United States.

What does InVivo Biosystems do?

InVivo Biosystems specializes in genome editing and preclinical research for neurological, metabolic, and rare monogenic diseases.

What stage is InVivo Biosystems at?

InVivo Biosystems is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 13, 2025.

MLA

"InVivo Biosystems — Funding & Investors." VCBacked, April 13, 2025, https://www.vcbacked.co/company/invivo-biosystems. Accessed July 2, 2026.

APA

VCBacked. (2025). InVivo Biosystems — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/invivo-biosystems

Wikipedia (cite web)

{{cite web |title=InVivo Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/invivo-biosystems |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 13, 2025.